CoChat
Sign Up
Cited by 272

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Rho family GTPases and their regulators in lymphocytes

Tybulewicz, Victor L. J., Henderson, Robert B.·2009·Nature Reviews Immunology
DOI 10.1038/nri2606PMC PMC4898593
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri2606

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 114

  1. Heasman, S. J. & Ridley, A. J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nature Rev. Mol. Cell Biol. 9, 690–701 (2008). · DOI · Paper page
  2. Wennerberg, K. & Der, C. J. Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117, 1301–1312 (2004). · DOI
  3. Bustelo, X. R., Sauzeau, V. & Berenjeno, I. M. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29, 356–370 (2007). · DOI
  4. Rossman, K. L., Der, C. J. & Sondek, J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nature Rev. Mol. Cell Biol. 6, 167–180 (2005). · DOI · Paper page
  5. Tcherkezian, J. & Lamarche-Vane, N. Current knowledge of the large RhoGAP family of proteins. Biol. Cell 99, 67–86 (2007). · DOI
  6. DerMardirossian, C. & Bokoch, G. M. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15, 356–363 (2005). · DOI
  7. Croker, B. A. et al. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168, 3376–3386 (2002). · DOI
  8. Walmsley, M. J. et al. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302, 459–462 (2003). · DOI · Paper page
  9. Gulbranson-Judge, A. et al. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur. J. Immunol. 29, 477–487 (1999). · DOI
  10. Doody, G. M. et al. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nature Immunol. 2, 542–547 (2001). · DOI
  11. Tedford, K. et al. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nature Immunol. 2, 548–555 (2001). · DOI
  12. Fujikawa, K. et al. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J. Exp. Med. 198, 1595–1608 (2003). · DOI
  13. Vigorito, E., Gambardella, L., Colucci, F., McAdam, S. & Turner, M. Vav proteins regulate peripheral B-cell survival. Blood 106, 2391–2398 (2005). · DOI
  14. Yamada, T., Kurosaki, T. & Hikida, M. Essential roles of mgcRacGAP in multilineage differentiation and survival of murine hematopoietic cells. Biochem. Biophys. Res. Commun. 372, 941–946 (2008). · DOI
  15. Kawashima, T. et al. A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors. Mol. Cell Biol. 29, 1796–1813 (2009). · DOI
  16. Saci, A. & Carpenter, C. L. RhoA GTPase regulates B cell receptor signaling. Mol. Cell 17, 205–214 (2005). · DOI
  17. Burbach, B. J., Medeiros, R. B., Mueller, K. L. & Shimizu, Y. T-cell receptor signaling to integrins. Immunol. Rev. 218, 65–81 (2007). · DOI
  18. Vigorito, E. et al. Immunological function in mice lacking the Rac-related GTPase RhoG. Mol. Cell Biol. 24, 719–729 (2004). · DOI
  19. Bachmann, M. F. et al. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens. J. Immunol. 163, 137–142 (1999). · DOI
  20. Inabe, K. et al. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195, 189–200 (2002). · DOI
  21. Vigorito, E. et al. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J. Immunol. 173, 3209–3214 (2004). · DOI
  22. Hebeis, B., Vigorito, E., Kovesdi, D. & Turner, M. Vav proteins are required for B-lymphocyte responses to LPS. Blood 106, 635–640 (2005). · DOI
  23. Stephenson, L. M., Miletic, A. V., Kloeppel, T., Kusin, S. & Swat, W. Vav proteins regulate the plasma cell program and secretory Ig production. J. Immunol. 177, 8620–8625 (2006). · DOI
  24. Missy, K. et al. αPIX Rho GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol. Cell. Biol. 28, 3776–3789 (2008). · DOI
  25. Girkontaite, I. et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nature Immunol. 2, 855–862 (2001). · DOI
  26. Rubtsov, A. et al. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 23, 527–538 (2005). References 27 and 28 analyse the role of LSC, which is a RHOA GEF, in B cell development and provide insights into the regulation of marginal zone B cell migration and retention. · DOI
  27. Nombela-Arrieta, C. et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase γ during T and B lymphocyte homing. Immunity 21, 429–441 (2004). · DOI
  28. Nombela-Arrieta, C. et al. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J. Exp. Med. 204, 497–510 (2007). · DOI
  29. Pearce, G. et al. Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs. Nature Immunol. 7, 827–834 (2006). · DOI
  30. Quemeneur, L., Angeli, V., Chopin, M. & Jessberger, R. SWAP-70 deficiency causes high-affinity plasma cell generation despite impaired germinal center formation. Blood 111, 2714–2724 (2008). · DOI
  31. Hakem, A. et al. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 19, 1974–1979 (2005). · DOI
  32. Liu, A. X., Rane, N., Liu, J. P. & Prendergast, G. C. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol. Cell Biol. 21, 6906–6912 (2001). · DOI
  33. Corre, I., Gomez, M., Vielkind, S. & Cantrell, D. A. Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T cell receptor responses in vivo. J. Exp. Med. 194, 903–914 (2001). · DOI
  34. Galandrini, R., Henning, S. W. & Cantrell, D. A. Different functions of the GTPase Rho in prothymocytes and late pre-T cells. Immunity 7, 163–174 (1997). · DOI
  35. Henning, S. W., Galandrini, R., Hall, A. & Cantrell, D. A. The GTPase Rho has a critical regulatory role in thymus development. EMBO J. 16, 2397–2407 (1997). · DOI
  36. Mullin, M. et al. The RhoA transcriptional program in pre-T cells. FEBS Lett. 581, 4309–4317 (2007). · DOI
  37. Gomez, M., Tybulewicz, V. & Cantrell, D. A. Control of pre-T cell proliferation and differentiation by the GTPase Rac-1. Nature Immunol. 1, 348–352 (2000). · DOI
  38. Gomez, M., Kioussis, D. & Cantrell, D. A. The GTPase Rac-1 controls cell fate in the thymus by diverting thymocytes from positive to negative selection. Immunity 15, 703–713 (2001). · DOI
  39. Lores, P., Morin, L., Luna, R. & Gacon, G. Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPase. Oncogene 15, 601–605 (1997). · DOI · Paper page
  40. Dumont, C. et al. Rac GTPases play critical roles in early T cell development. Blood 113, 3990–3998 (2009). · DOI · Paper page
  41. Guo, F., Cancelas, J. A., Hildeman, D., Williams, D. A. & Zheng, Y. Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. Blood 112, 1767–1775 (2008). Reference 44, together with references 8 and 43, examines the effects of removing RAC1 and RAC2 on B and T cell development. · DOI · Paper page
  42. Fischer, K. D. et al. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CD8+ thymocytes. Nature 374, 474–477 (1995). · DOI
  43. Tarakhovsky, A. et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467–470 (1995). · DOI
  44. Turner, M. et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7, 451–460 (1997). · DOI
  45. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H. & Swat, W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374, 470–473 (1995). References 46–49 highlight the key role of VAV1 in T cell development and TCR signalling.
  46. Kong, Y. Y. et al. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med. 188, 2099–2111 (1998). · DOI
  47. Reynolds, L. F. et al. Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos and RasGRP1. J. Biol. Chem. 279, 18239–18246 (2004). · DOI
  48. Reynolds, L. F. et al. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways. J. Exp. Med. 195, 1103–1114 (2002). · DOI
  49. Swat, W. et al. Essential role for Vav1 in activation, but not development, of γδ T cells. Int. Immunol. 15, 215–221 (2003). · DOI
  50. Harenberg, A., Girkontaite, I., Giehl, K. & Fischer, K. D. The Lsc RhoGEF mediates signaling from thromboxane A2 to actin polymerization and apoptosis in thymocytes. Eur. J. Immunol. 35, 1977–1986 (2005). · DOI
  51. Klinger, M. B., Guilbault, B. & Kay, R. J. The RhoA- and CDC42-specific exchange factor Dbs promotes expansion of immature thymocytes and deletion of double-positive and single-positive thymocytes. Eur. J. Immunol. 34, 806–816 (2004). · DOI
  52. Sanui, T. et al. DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-θ and LFA-1, in T cells. Immunity 19, 119–129 (2003). · DOI
  53. Kunisaki, Y. et al. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J. Cell Biol. 174, 647–652 (2006). · DOI
  54. Gupta, S. et al. T cell receptor engagement leads to the recruitment of IBP, a novel guanine nucleotide exchange factor, to the immunological synapse. J. Biol. Chem. 278, 43541–43549 (2003). · DOI
  55. Gupta, S. et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum. Immunol. 64, 389–401 (2003). · DOI
  56. Tanaka, Y. et al. SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells. Immunity 18, 403–414 (2003). · DOI
  57. Fanzo, J. C. et al. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J. Clin. Invest. 116, 703–714 (2006). · DOI
  58. Becart, S. et al. SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling. J. Clin. Invest. 117, 2164–2175 (2007). · DOI
  59. Yu, H., Leitenberg, D., Li, B. & Flavell, R. A. Deficiency of small GTPase Rac2 affects T cell activation. J. Exp. Med. 194, 915–926 (2001). · DOI
  60. Dorn, T. et al. RhoH is important for positive thymocyte selection and T-cell receptor signaling. Blood 109, 2346–2355 (2007). · DOI · Paper page
  61. Bustelo, X. R., Ledbetter, J. A. & Barbacid, M. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 356, 68–71 (1992). · DOI
  62. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. & Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385, 169–172 (1997). · DOI
  63. Han, J. et al. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17, 1346–1353 (1997). · DOI
  64. Margolis, B. et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 356, 71–74 (1992). · DOI
  65. Fischer, K.-D. et al. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8, 554–562 (1998). · DOI
  66. Holsinger, L. J. et al. Defects in actin cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8, 563–572 (1998). · DOI
  67. Penninger, J. M. et al. The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation. Eur. J. Immunol. 29, 1709–1718 (1999). · DOI
  68. Costello, P. S. et al. The Rho-family GTP exchange factor Vav is a critical transducer of TCR signals to the calcium, ERK and NF-κB pathways. Proc. Natl Acad. Sci. USA 96, 3035–3040 (1999). · DOI
  69. Charvet, C., Auberger, P., Tartare-Deckert, S., Bernard, A. & Deckert, M. Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway. J. Biol. Chem. 277, 15376–15384 (2002). · DOI
  70. Charvet, C. et al. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J. Immunol. 177, 5024–5031 (2006). · DOI
  71. Cao, Y. et al. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. EMBO J. 21, 4809–4819 (2002). · DOI
  72. Wood, J. E., Schneider, H. & Rudd, C. E. TCR and TCR–CD28 engagement of protein-kinase B (PKB/AKT) and gylcogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1. J. Biol. Chem. 281, 32385–32394 (2006). · DOI
  73. Villalba, M. et al. Translocation of PKCθ in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157, 253–263 (2002). · DOI
  74. Villalba, M. et al. A novel functional interaction between Vav and PKCθ is required for TCR-induced T cell activation. Immunity 12, 151–160 (2000). · DOI
  75. Puga, I., Rao, A. & Macian, F. Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells. Immunity 29, 193–204 (2008). · DOI
  76. Ardouin, L. et al. Vav1 transduces TCR signals required for LFA-1 function and cell polarization at the immunological synapse. Eur. J. Immunol. 33, 790–797 (2003). · DOI
  77. Krawczyk, C. et al. Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 16, 331–343 (2002). · DOI
  78. Villalba, M. et al. Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells. J. Cell Biol. 155, 331–338 (2001). · DOI
  79. Wülfing, C., Bauch, A., Crabtree, G. R. & Davis, M. M. The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte–antigen-presenting cell interface. Proc. Natl Acad. Sci. USA 97, 10150–10155 (2000). · DOI
  80. Gomez, T. S. et al. Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse. Nature Immunol. 6, 261–270 (2005). · DOI
  81. Faure, S. et al. ERM proteins regulate cytoskeleton relaxation promoting T cell–APC conjugation. Nature Immunol. 5, 272–279 (2004). · DOI
  82. Tybulewicz, V., Ardouin, L., Prisco, A. & Reynolds, L. F. Vav1: a key signal transducer downstream of the TCR. Immunol. Rev. 192, 42–52 (2003). · DOI
  83. Tybulewicz, V. L. J. Vav-family proteins in T-cell signalling. Curr. Opin. Immunol. 17, 267–274 (2005). · DOI
  84. Kuhne, M. R., Ku, G. & Weiss, A. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation. J. Biol. Chem. 275, 2185–2190 (2000). · DOI
  85. Billadeau, D. D., Mackie, S. M., Schoon, R. A. & Leibson, P. J. Specific subdomains of Vav differentially affect T cell and NK cell activation. J. Immunol. 164, 3971–3981 (2000). · DOI
  86. Houlard, M. et al. Vav1 is a component of transcriptionally active complexes. J. Exp. Med. 195, 1115–1127 (2002). · DOI
  87. Blanchet, F., Cardona, A., Letimier, F. A., Hershfield, M. S. & Acuto, O. CD28 costimulatory signal induces protein arginine methylation in T cells. J. Exp. Med. 202, 371–377 (2005). · DOI
  88. Phee, H., Abraham, R. T. & Weiss, A. Dynamic recruitment of PAK1 to the immunological synapse is mediated by PIX independently of SLP-76 and Vav1. Nature Immunol. 6, 608–617 (2005). · DOI
  89. Nishihara, H. et al. DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines. Blood 100, 3968–3974 (2002). · DOI · Paper page
  90. Chen, Q. et al. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 29, 899–911 (2008). This paper shows that the GEF IBP regulates T H cell development by inhibiting IRF4. · DOI
  91. Becart, S. et al. Tyrosine-phosphorylation-dependent translocation of the SLAT protein to the immunological synapse is required for NFAT transcription factor activation. Immunity 29, 704–719 (2008). · DOI
  92. Ishizaki, H. et al. Defective chemokine-directed lymphocyte migration and development in the absence of Rho guanosine diphosphate-dissociation inhibitors α and β. J. Immunol. 177, 8512–8521 (2006). · DOI
  93. Li, B. et al. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science 288, 2219–2222 (2000). · DOI · Paper page
  94. Croker, B. A. et al. Rac2-deficient mice display perturbed T-cell distribution and chemotaxis, but only minor abnormalities in TH1 responses. Immunol. Cell Biol. 80, 231–240 (2002). · DOI
  95. Tanaka, Y., So, T., Lebedeva, S., Croft, M. & Altman, A. Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood 106, 1286–1295 (2005). · DOI
  96. Korn, T. et al. Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming. J. Neuroimmunol. 139, 17–26 (2003). · DOI
  97. Weckbecker, G. et al. Strongly reduced alloreactivity and long-term survival times of cardiac allografts in Vav1- and Vav1/Vav2-knockout mice. Transpl. Int. 20, 353–364 (2007). · DOI
  98. Tanaka, Y. et al. T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-α subunit controlled by the Rac activator Dock2. Nature Immunol. 8, 1067–1075 (2007). This paper shows that DOCK2 regulates the intracellular trafficking of the IL-4 receptor α-subunit. · DOI
  99. Vielkind, S., Gallagher-Gambarelli, M., Gomez, M., Hinton, H. J. & Cantrell, D. A. Integrin regulation by RhoA in thymocytes. J. Immunol. 175, 350–357 (2005). · DOI
  100. Bolomini-Vittori, M. et al. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nature Immunol. 10, 185–194 (2009). · DOI
  101. Cherry, L. K., Li, X., Schwab, P., Lim, B. & Klickstein, L. B. RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes. Nature Immunol. 5, 961–967 (2004). · DOI · Paper page
  102. Vicente-Manzanares, M. et al. Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav. Blood 105, 3026–3034 (2005). · DOI
  103. Shulman, Z. et al. DOCK2 regulates chemokine-triggered lateral lymphocyte motility but not transendothelial migration. Blood 108, 2150–2158 (2006). · DOI
  104. Krummel, M. F. & Macara, I. Maintenance and modulation of T cell polarity. Nature Immunol. 7, 1143–1149 (2006). · DOI
  105. Stowers, L., Yelon, D., Berg, L. J. & Chant, J. Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42. Proc. Natl Acad. Sci. USA 92, 5027–5031 (1995). · DOI
  106. D'Souza-Schorey, C., Boettner, B. & Van Aelst, L. Rac regulates integrin-mediated spreading and increased adhesion of T lymphocytes. Mol. Cell Biol. 18, 3936–3946 (1998). · DOI
  107. del Pozo, M. A., Vicente-Manzanares, M., Tejedor, R., Serrador, J. M. & Sanchez-Madrid, F. Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. Eur. J. Immunol. 29, 3609–3620 (1999). · DOI
  108. Gerard, A., Mertens, A. E., van der Kammen, R. A. & Collard, J. G. The Par polarity complex regulates Rap1- and chemokine-induced T cell polarization. J. Cell Biol. 176, 863–875 (2007). · DOI
  109. Volinsky, N., Gantman, A. & Yablonski, D. A Pak- and Pix-dependent branch of the SDF-1α signalling pathway mediates T cell chemotaxis across restrictive barriers. Biochem. J. 397, 213–222 (2006). · DOI
  110. Saveliev, A. & Tybulewicz, V. L. Lymphocyte signaling: beyond knockouts. Nature Immunol. 10, 361–364 (2009). · DOI
  111. Weisz Hubsman, M., Volinsky, N., Manser, E., Yablonski, D. & Aronheim, A. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp. Biochem. J. 404, 487–497 (2007). · DOI · Paper page
  112. Smith, A., Bracke, M., Leitinger, B., Porter, J. C. & Hogg, N. LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment. J. Cell Sci. 116, 3123–3133 (2003). · DOI
  113. Boureux, A., Vignal, E., Faure, S. & Fort, P. Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol. Biol. Evol. 24, 203–216 (2007). · DOI · Paper page
  114. Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107–111 (2007). · DOI

Cited by

Metadata

Authors
Tybulewicz, V. L. J., & Henderson, R. B.
Venue
Nature Reviews Immunology
Publisher
Springer Science and Business Media LLC
Published
2009-08-21
Volume
9
Issue
9
Pages
630-644
ISSN
  • 1474-1733
  • 1474-1741
DOI
10.1038/nri2606
PMC
PMC4898593
Cited by
272
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review